(1H-Imidazo[4,5-c]pyridin-2-yl)-1,2,5-oxadiazol-3-ylamine derivatives: A novel class of potent MSK-1-inhibitors
摘要:
A novel series of imidazo[4,5-c]pyridines bearing a 1,2,5-oxadiazol-3-ylamine functionality has been developed. These are potent inhibitors of mitogen and stress-activated protein kinase-1. (c) 2005 Elsevier Ltd. All rights reserved.
(1H-Imidazo[4,5-c]pyridin-2-yl)-1,2,5-oxadiazol-3-ylamine derivatives: A novel class of potent MSK-1-inhibitors
摘要:
A novel series of imidazo[4,5-c]pyridines bearing a 1,2,5-oxadiazol-3-ylamine functionality has been developed. These are potent inhibitors of mitogen and stress-activated protein kinase-1. (c) 2005 Elsevier Ltd. All rights reserved.
Dihydropyridine antiallergic and antiinflammatory agents
申请人:Pfizer Inc.
公开号:US04904671A1
公开(公告)日:1990-02-27
4-Aryl-2,6-disubstituted-3,5-dicarbamyl-1,4-dihydropyridines and 4-Aryl-2,6-disubstituted-3-alkoxycarbonyl-5-carbamyl-1,4-dihydropyridines as antiallergy and antiinflammatory agents.
Dihydropyridines, their preparation and their use as PAF-antagonists
申请人:Pfizer Limited
公开号:EP0330327A2
公开(公告)日:1989-08-30
Dihydropyridine PAF antagonists useful in the treatment of allergic and inflammatory conditions and having the formula:-
where Ar is an optionally substituted phenyl group;
R and R¹ and each C₁-C₄ alkyl or aryl;
R² and R³ are each H or C₁-C₆ alkyl or may be joined together to form with the N atom to which they are attached certain heterocyclic groups,
or R² is H or C₁-C₄ alkyl and R³ is either (a) C₃-C₇ cycloalkyl, aryl, indanyl or heteroaryl, or (b) a C₁-C₄ alkyl group substituted by one or two substituents each selected from C₃-C₇ cycloalkyl, C₁-C₄ alkoxycarbonyl, aryl and heteroaryl;
X is O or NH;
Y is -(CH₂)m- where m is 4 or 5 or
where n is 1 or 2 and p is 0 or 1;
and Z is 5- or 6-membered nitrogen-containing heterocyclic group optionally benzo-fused or fused to a further heterocyclic group.
二氢吡啶类 PAF 拮抗剂,可用于治疗过敏性和炎症性病症,其式如下: - 其中 Ar 为任选取代的苯基
其中 Ar 是任选取代的苯基;
R 和 R¹ 分别是 C₁-C₄ 烷基或芳基;
R²和R³各自为H或C₁-C₆烷基,或可连接在一起,与所连接的N原子形成某些杂环基团、
或 R² 是 H 或 C₁-C₄ 烷基,R³ 是 (a) C₃-C₇ 环烷基、芳基、茚满基或杂芳基、或 (b) 被一个或两个各自选自 C₃-C₇ 环烷基、C₁-C₄ 烷氧基羰基、芳基和杂芳基的取代基取代的 C₁-C₄ 烷基;
X 是 O 或 NH
Y 是-(CH₂)m-,其中 m 是 4 或 5,或
其中 n 为 1 或 2,p 为 0 或 1;
Z 是 5 或 6 元含氮杂环基团,可选择与苯并合或与另一个杂环基团并合。
US4904671A
申请人:——
公开号:US4904671A
公开(公告)日:1990-02-27
(1H-Imidazo[4,5-c]pyridin-2-yl)-1,2,5-oxadiazol-3-ylamine derivatives: A novel class of potent MSK-1-inhibitors
作者:Mark J. Bamford、Michael J. Alberti、Nicholas Bailey、Susannah Davies、David K. Dean、Alessandra Gaiba、Stephen Garland、John D. Harling、David K. Jung、Terence A. Panchal、Christopher A. Parr、Jon G. Steadman、Andrew K. Takle、James T. Townsend、David M. Wilson、Jason Witherington
DOI:10.1016/j.bmcl.2005.05.021
日期:2005.7
A novel series of imidazo[4,5-c]pyridines bearing a 1,2,5-oxadiazol-3-ylamine functionality has been developed. These are potent inhibitors of mitogen and stress-activated protein kinase-1. (c) 2005 Elsevier Ltd. All rights reserved.